Form 4: Argan Inc. Director Exercises Stock Options, Reports Beneficial Ownership Changes
SEC Form 4 Filing
Director John R. Jeffrey Jr. exercised stock options to purchase 10,000 shares of Argan Inc. common stock at $60.05 per share on June 12, 2024, using a net settle approach.
Summary
- On June 12, 2024, John R. Jeffrey Jr., a director of Argan Inc., exercised options to purchase 10,000 shares of the company's common stock.
- The exercise price was $60.05 per share.
- The options were awarded on June 22, 2017.
- The exercise was conducted using a net settle approach.
- Following the transaction, Jeffrey directly owns 4,698 shares of common stock and indirectly owns 8,000 shares through an IRA.
- After the transaction, Jeffrey directly owns 41,500 options to purchase common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.
Positives
- The exercise of options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the holdings and transactions of company insiders.
Stakeholder Impact
- Shareholders are informed about the insider transaction, promoting transparency.
Key Dates
| Date | Description |
|---|---|
| 06/22/2017 | Date the options were awarded. |
| 06/12/2024 | Date of the transaction (option exercise). |
| 06/14/2024 | Date of signature on the Form 4 filing. |
| 06/22/2027 | Expiration date of the options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.